CryoCath to present at the 2007 RBC Healthcare Conference
    Toronto Stock Exchange Symbol: CYT

    MONTREAL, Dec. 6 /CNW/ - CryoCath Technologies Inc. (TSX: CYT), the
global leader in cryotherapy products to treat cardiac arrhythmias, today
announced that Jan Keltjens, President and CEO of CryoCath, will present on
the 'Breaking Through Old Barriers: New Opportunities' panel at the 2007 RBC
Healthcare Conference at The Westin New York at Times Square in New York City
on Thursday, December 13. Mr. Keltjens will present a market outlook and
discuss some recent events and upcoming milestones, including the STOP AF IDE
Trial for Arctic Front(R), the Company's minimally invasive cryo-balloon
catheter designed specifically to treat paroxysmal atrial fibrillation.
    A live webcast of CryoCath's presentation, at 9:00 a.m. on Thursday,
December 13, will be available at for 30 days.

    About CryoCath

    CryoCath - - is a medical technology company that leads
the world in cryotherapy products to treat cardiovascular disease. With a
priority focus on providing physicians with a complete solution of catheter
products to treat cardiac arrhythmias, CryoCath has multiple products approved
in the U.S., across Europe and several ROW countries. The Company is
developing additional products to expand its pipeline of products to treat
cardiac arrhythmias.

    This press release includes "forward-looking statements" that are subject
to risks and uncertainties, including with respect to the timing of regulatory
trials and their outcome. For information identifying legislative or
regulatory, economic, climatic, currency, technological, competitive and other
important factors that could cause actual results to differ materially from
those anticipated in the forward looking statements, see CryoCath's annual
report available at under the heading Risks and Uncertainties in
the Management's Discussion and Analysis section.

    %SEDAR: 00015053EF

For further information:

For further information: visit our website at, or
contact: Michael Moore, Investor Relations, Phone: (416) 815-0700 ext. 241,
Fax: (416) 815-0080, E-mail:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890